Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Implementation interventions for musculoskeletal programs of care in the active military and barriers, facilitators, and outcomes of implementation: a scoping review.

Cancelliere C, Sutton D, Côté P, French SD, Taylor-Vaisey A, Mior SA.

Implement Sci. 2019 Aug 16;14(1):82. doi: 10.1186/s13012-019-0931-1. Review.

2.

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.

Lazzari L, Corti G, Picco G, Isella C, Montone M, Arcella P, Durinikova E, Zanella ER, Novara L, Barbosa F, Cassingena A, Cancelliere C, Medico E, Sartore-Bianchi A, Siena S, Garnett MJ, Bertotti A, Trusolino L, Di Nicolantonio F, Linnebacher M, Bardelli A, Arena S.

Clin Cancer Res. 2019 Aug 2. doi: 10.1158/1078-0432.CCR-18-3440. [Epub ahead of print]

PMID:
31375513
3.

Chiropractic services in the active duty military setting: a scoping review.

Mior S, Sutton D; Daphne To, Cancelliere C, French S, Taylor-Vaisey A, Côté P.

Chiropr Man Therap. 2019 Jul 15;27:45. doi: 10.1186/s12998-019-0259-6. eCollection 2019. Review.

4.

Evolving neoantigen profiles in colorectal cancers with DNA repair defects.

Rospo G, Lorenzato A, Amirouchene-Angelozzi N, Magrì A, Cancelliere C, Corti G, Negrino C, Amodio V, Montone M, Bartolini A, Barault L, Novara L, Isella C, Medico E, Bertotti A, Trusolino L, Germano G, Di Nicolantonio F, Bardelli A.

Genome Med. 2019 Jun 28;11(1):42. doi: 10.1186/s13073-019-0654-6.

5.

Brain Drain: Psychosocial Factors Influence Recovery Following Mild Traumatic Brain Injury: 3 Recommendations for Clinicians Assessing Psychosocial Factors.

Cancelliere C, Mohammed RJ.

J Orthop Sports Phys Ther. 2019 Jun 1:1-10. doi: 10.2519/jospt.2019.8849. [Epub ahead of print]

PMID:
31154953
6.

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.

Barault L, Amatu A, Siravegna G, Ponzetti A, Moran S, Cassingena A, Mussolin B, Falcomatà C, Binder AM, Cristiano C, Oddo D, Guarrera S, Cancelliere C, Bustreo S, Bencardino K, Maden S, Vanzati A, Zavattari P, Matullo G, Truini M, Grady WM, Racca P, Michels KB, Siena S, Esteller M, Bardelli A, Sartore-Bianchi A, Di Nicolantonio F.

Gut. 2018 Nov;67(11):1995-2005. doi: 10.1136/gutjnl-2016-313372. Epub 2017 Oct 5.

7.

Epidemiology of Isolated Versus Nonisolated Mild Traumatic Brain Injury Treated in Emergency Departments in the United States, 2006-2012: Sociodemographic Characteristics.

Cancelliere C, Coronado VG, Taylor CA, Xu L.

J Head Trauma Rehabil. 2017 Jul/Aug;32(4):E37-E46. doi: 10.1097/HTR.0000000000000260.

8.

Healthy and productive workers: using intervention mapping to design a workplace health promotion and wellness program to improve presenteeism.

Ammendolia C, Côté P, Cancelliere C, Cassidy JD, Hartvigsen J, Boyle E, Soklaridis S, Stern P, Amick B 3rd.

BMC Public Health. 2016 Nov 25;16(1):1190.

9.

Factors affecting return to work after injury or illness: best evidence synthesis of systematic reviews.

Cancelliere C, Donovan J, Stochkendahl MJ, Biscardi M, Ammendolia C, Myburgh C, Cassidy JD.

Chiropr Man Therap. 2016 Sep 8;24(1):32. doi: 10.1186/s12998-016-0113-z. eCollection 2016. Review.

10.

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.

Oddo D, Sennott EM, Barault L, Valtorta E, Arena S, Cassingena A, Filiciotto G, Marzolla G, Elez E, van Geel RM, Bartolini A, Crisafulli G, Boscaro V, Godfrey JT, Buscarino M, Cancelliere C, Linnebacher M, Corti G, Truini M, Siravegna G, Grasselli J, Gallicchio M, Bernards R, Schellens JH, Tabernero J, Engelman JA, Sartore-Bianchi A, Bardelli A, Siena S, Corcoran RB, Di Nicolantonio F.

Cancer Res. 2016 Aug 1;76(15):4504-15. doi: 10.1158/0008-5472.CAN-16-0396. Epub 2016 Jun 16.

11.

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.

Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, Cancelliere C, Di Fiore PP, Bardelli A, Penna G, Rescigno M.

Nat Med. 2016 Jun;22(6):624-31. doi: 10.1038/nm.4078. Epub 2016 May 2.

PMID:
27135741
12.

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.

Conti A, Majorini MT, Elliott R, Ashworth A, Lord CJ, Cancelliere C, Bardelli A, Seneci P, Walczak H, Delia D, Lecis D.

Oncotarget. 2015 May 10;6(13):10994-1008.

13.

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.

Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G, Buscarino M, Isella C, Lamba S, Martinoglio B, Veronese S, Siena S, Sartore-Bianchi A, Beccuti M, Mottolese M, Linnebacher M, Cordero F, Di Nicolantonio F, Bardelli A.

Nat Commun. 2015 Apr 30;6:7002. doi: 10.1038/ncomms8002.

14.

Beyond the spine: a new clinical research priority.

Donovan J, Cassidy JD, Cancelliere C, Poulsen E, Stochkendahl MJ, Kilsgaard J, Blanchette MA, Hartvigsen J.

J Can Chiropr Assoc. 2015 Mar;59(1):6-12.

16.

Summary of the findings of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Donovan J, Cancelliere C, Cassidy JD.

Chiropr Man Therap. 2014 Nov 4;22(1):38. doi: 10.1186/s12998-014-0038-3. eCollection 2014.

17.

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

Lamba S, Russo M, Sun C, Lazzari L, Cancelliere C, Grernrum W, Lieftink C, Bernards R, Di Nicolantonio F, Bardelli A.

Cell Rep. 2014 Sep 11;8(5):1475-83. doi: 10.1016/j.celrep.2014.07.033. Epub 2014 Sep 4.

18.

Introduction to the findings of the International Collaboration on Mild Traumatic Brain Injury Prognosis: what is a prognostic study?

Salmi LR, Cassidy JD, Holm L, Cancelliere C, Côté P, Borg J.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S95-100. doi: 10.1016/j.apmr.2013.10.026.

PMID:
24581916
19.

Methodological issues and research recommendations for prognosis after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Kristman VL, Borg J, Godbolt AK, Salmi LR, Cancelliere C, Carroll LJ, Holm LW, Nygren-de Boussard C, Hartvigsen J, Abara U, Donovan J, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S265-77. doi: 10.1016/j.apmr.2013.04.026.

PMID:
24581912
20.

Nonsurgical interventions after mild traumatic brain injury: a systematic review. Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Nygren-de Boussard C, Holm LW, Cancelliere C, Godbolt AK, Boyle E, Stålnacke BM, Hincapié CA, Cassidy JD, Borg J.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S257-64. doi: 10.1016/j.apmr.2013.10.009. Review.

PMID:
24581911
21.

Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Godbolt AK, Cancelliere C, Hincapié CA, Marras C, Boyle E, Kristman VL, Coronado VG, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S245-56. doi: 10.1016/j.apmr.2013.06.036. Review.

PMID:
24581910
22.

Systematic review of the risk of Parkinson's disease after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Marras C, Hincapié CA, Kristman VL, Cancelliere C, Soklaridis S, Li A, Borg J, af Geijerstam JL, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S238-44. doi: 10.1016/j.apmr.2013.08.298. Review.

PMID:
24581909
23.

Systematic review of prognosis after mild traumatic brain injury in the military: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Boyle E, Cancelliere C, Hartvigsen J, Carroll LJ, Holm LW, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S230-7. doi: 10.1016/j.apmr.2013.08.297. Review.

PMID:
24581908
24.

Systematic review of prognosis and return to play after sport concussion: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Cancelliere C, Hincapié CA, Keightley M, Godbolt AK, Côté P, Kristman VL, Stålnacke BM, Carroll LJ, Hung R, Borg J, Nygren-de Boussard C, Coronado VG, Donovan J, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S210-29. doi: 10.1016/j.apmr.2013.06.035. Review.

PMID:
24581907
25.

Systematic review of return to work after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Cancelliere C, Kristman VL, Cassidy JD, Hincapié CA, Côté P, Boyle E, Carroll LJ, Stålnacke BM, Nygren-de Boussard C, Borg J.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S201-9. doi: 10.1016/j.apmr.2013.10.010. Review.

PMID:
24581906
26.

Psychosocial consequences of mild traumatic brain injury in children: results of a systematic review by the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Keightley ML, Côté P, Rumney P, Hung R, Carroll LJ, Cancelliere C, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S192-200. doi: 10.1016/j.apmr.2013.12.018. Review.

PMID:
24581905
27.

Systematic review of the clinical course, natural history, and prognosis for pediatric mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Hung R, Carroll LJ, Cancelliere C, Côté P, Rumney P, Keightley M, Donovan J, Stålnacke BM, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S174-91. doi: 10.1016/j.apmr.2013.08.301. Review.

PMID:
24581904
28.

Systematic review of the prognosis after mild traumatic brain injury in adults: cognitive, psychiatric, and mortality outcomes: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Carroll LJ, Cassidy JD, Cancelliere C, Côté P, Hincapié CA, Kristman VL, Holm LW, Borg J, Nygren-de Boussard C, Hartvigsen J.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S152-73. doi: 10.1016/j.apmr.2013.08.300. Review.

PMID:
24581903
29.

Systematic review of self-reported prognosis in adults after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Cassidy JD, Cancelliere C, Carroll LJ, Côté P, Hincapié CA, Holm LW, Hartvigsen J, Donovan J, Nygren-de Boussard C, Kristman VL, Borg J.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S132-51. doi: 10.1016/j.apmr.2013.08.299. Review.

PMID:
24581902
30.

Systematic search and review procedures: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Cancelliere C, Cassidy JD, Li A, Donovan J, Côté P, Hincapié CA.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S101-31. doi: 10.1016/j.apmr.2013.12.001.

PMID:
24581901
31.

BRAF V600E is a determinant of sensitivity to proteasome inhibitors.

Zecchin D, Boscaro V, Medico E, Barault L, Martini M, Arena S, Cancelliere C, Bartolini A, Crowley EH, Bardelli A, Gallicchio M, Di Nicolantonio F.

Mol Cancer Ther. 2013 Dec;12(12):2950-61. doi: 10.1158/1535-7163.MCT-13-0243. Epub 2013 Oct 9.

32.

Protocol for a systematic review of prognosis after mild traumatic brain injury: an update of the WHO Collaborating Centre Task Force findings.

Cancelliere C, Cassidy JD, Côté P, Hincapié CA, Hartvigsen J, Carroll LJ, Marras C, Boyle E, Kristman V, Hung R, Stålnacke BM, Rumney P, Coronado V, Holm LW, Borg J, Nygren-de Boussard C, Af Geijerstam JL, Keightley M.

Syst Rev. 2012 Feb 23;1:17. doi: 10.1186/2046-4053-1-17.

33.

Are workplace health promotion programs effective at improving presenteeism in workers? A systematic review and best evidence synthesis of the literature.

Cancelliere C, Cassidy JD, Ammendolia C, Côté P.

BMC Public Health. 2011 May 26;11:395. doi: 10.1186/1471-2458-11-395. Review.

34.

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.

Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, Macarulla T, Russo M, Cancelliere C, Zecchin D, Mazzucchelli L, Sasazuki T, Shirasawa S, Geuna M, Frattini M, Baselga J, Gallicchio M, Biffo S, Bardelli A.

J Clin Invest. 2010 Aug;120(8):2858-66. doi: 10.1172/JCI37539. Epub 2010 Jul 26.

35.

Profile.

Cancelliere C.

J Can Chiropr Assoc. 2010 Mar;54(1):10. No abstract available.

36.

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses.

Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20864-9. doi: 10.1073/pnas.0808757105. Epub 2008 Dec 23.

Supplemental Content

Loading ...
Support Center